Clinical Research Directory
Browse clinical research sites, groups, and studies.
Placebo-controlled Study to Evaluate the Safety and Efficacy of GLK-221 Ophthalmic Solution in Subjects With Keratoconus
Sponsor: Glaukos Corporation
Summary
Multi-center, parallel-group, placebo-controlled trial designed to assess the safety and efficacy of twice-daily topically administered GLK-221 Ophthalmic Solution in subjects with keratoconus.
Official title: Multicenter, Randomized, Double-Masked, Placebo-Controlled Study to Evaluate the Safety and Efficacy of GLK-221 Ophthalmic Solution in Subjects With Keratoconus
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2025-12-23
Completion Date
2027-04
Last Updated
2026-02-10
Healthy Volunteers
No
Conditions
Interventions
GLK-221 Ophthalmic Solution
GLK-221 Ophthalmic Solution administered twice daily to both eyes
Placebo Ophthalmic Solution
Placebo Ophthalmic Solution administered twice daily to both eyes
Locations (1)
Glaukos Clinical Study Site
Westerville, Ohio, United States